Twin Securities, Inc. Top Holdings and 13F Report (2026) About Twin Securities, Inc.Investment ActivityTwin Securities, Inc. has $206.10 million in total holdings as of March 31, 2026.Twin Securities, Inc. owns shares of 16 different stocks, but just 4 companies or ETFs make up 80% of its holdings.Approximately 53.67% of the portfolio was purchased this quarter.About 79.43% of the portfolio was sold this quarter.This quarter, Twin Securities, Inc. has purchased 16 new stocks and bought additional shares in 6 stocks.Twin Securities, Inc. sold shares of 1 stock and completely divested from 8 stocks this quarter.Largest Holdings Electronic Arts $91,119,289Warner Bros. Discovery $35,695,666Clearwater Analytics $27,530,728Hologic $13,533,331Kenvue $8,284,113 Largest New Holdings this Quarter 76155X100 - Revolution Medicines $7,545,919 Holding03940C100 - Arcellx $6,198,213 Holding880881107 - Terns Pharmaceuticals $6,113,306 Holding03753U106 - Apellis Pharmaceuticals $5,126,911 Holding68278B107 - ONESTREAM INC $1,448,928 Holding Largest Purchases this Quarter Electronic Arts 207,112 shares (about $42.22M)Clearwater Analytics 1,114,776 shares (about $26.36M)Revolution Medicines 77,593 shares (about $7.55M)Hologic 94,523 shares (about $7.14M)Arcellx 53,982 shares (about $6.20M) Largest Sales this Quarter Surgery Partners 160,233 shares (about $1.91M) Sector Allocation Over TimeMap of 500 Largest Holdings ofTwin Securities, Inc. Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorEAElectronic Arts$91,119,289$42,223,924 â–²86.4%446,94844.2%Consumer DiscretionaryWBDWarner Bros. Discovery$35,695,666$4,526,122 â–²14.5%1,299,91517.3%Consumer DiscretionaryCWANClearwater Analytics$27,530,728$26,364,452 â–²2,260.6%1,164,09013.4%Computer and TechnologyHOLXHologic$13,533,331$7,144,993 â–²111.8%179,0366.6%MedicalKVUEKenvue$8,284,113$1,291,862 â–²18.5%480,5174.0%Consumer StaplesRVMDRevolution Medicines$7,545,919$7,545,919 â–²New Holding77,5933.7%MedicalACLXArcellx$6,198,213$6,198,213 â–²New Holding53,9823.0%MedicalTERNTerns Pharmaceuticals$6,113,306$6,113,306 â–²New Holding115,9583.0%MedicalAPLSApellis Pharmaceuticals$5,126,911$5,126,911 â–²New Holding127,4402.5%MedicalONESTREAM INC$1,448,928$1,448,928 â–²New Holding60,3720.7%CL ATTWOTake-Two Interactive Software$1,283,750$1,283,750 â–²New Holding6,5000.6%Consumer DiscretionaryDAWNDay One Biopharmaceuticals$678,061$678,061 â–²New Holding31,6260.3%MedicalATRIUM THERAPEUTICS INC$667,337$667,337 â–²New Holding49,9130.3%COMTIC SOLUTIONS INC$508,8910.0%77,3390.2%COMMANUManchester United$250,954$5,887 â–²2.4%14,9200.1%Consumer DiscretionarySGRYSurgery Partners$119,498$1,909,977 â–¼-94.1%10,0250.1%MedicalCYBRCyberArk Software$0$59,390,659 â–¼-100.0%00.0%Computer and TechnologyEXASExact Sciences$0$49,113,299 â–¼-100.0%00.0%MedicalRNAAvidity Biosciences$0$26,337,837 â–¼-100.0%00.0%MedicalCFLTConfluent$0$15,285,897 â–¼-100.0%00.0%Computer and TechnologyNSCNorfolk Southern$0$7,275,744 â–¼-100.0%00.0%TransportationCDAYCeridian HCM$0$2,713,908 â–¼-100.0%00.0%Computer and TechnologyCIDARA THERAPEUTICS INC$0$1,082,361 â–¼-100.0%00.0%COM NEWMLYSMineralys Therapeutics$0$607,386 â–¼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.